Users may experience increased energy levels, improved sleep quality, reduced appetite, and enhanced mood
Minoxidil has a solid evidence base and is one of the recognised treatments for pattern hair loss, whereas copper peptides do not have comparable human trials behind them
For serious hair loss concerns, AHK-CU is the better primary choice, potentially combined with GHK-CU for scalp health
it only affects bioavailability and efficacy.
How does BPC 157 compare to a peptide like GHK-Cu for skin
The breadth of documented activity reflects what the original investigators have described as systems-level pharmacology: rather than acting through a single high-affinity receptor, BPC-157 appears to modulate multiple intersecting cellular pathways including nitric oxide signalling, growth-factor receptor expression, dopamine and serotonin metabolism, and angiogenic vessel formation